Assessment of the Mutational Status of NSCLC Using Hypermetabolic Circulating Tumor Cells

Molecular characterization is currently a key step in NSCLC therapy selection. Circulating tumor cells (CTC) are excellent candidates for downstream analysis, but technology is still lagging behind. In this work, we show that the mutational status of NSCLC can be assessed on hypermetabolic CTC, dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Turetta, Matteo, Bulfoni, Michela, Brisotto, Giulia, Fasola, Gianpiero, Zanello, Andrea, Biscontin, Eva, Mariuzzi, Laura, Steffan, Agostino, Di Loreto, Carla, Cesselli, Daniela, Del Ben, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115779/
https://www.ncbi.nlm.nih.gov/pubmed/30110953
http://dx.doi.org/10.3390/cancers10080270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115779/
https://www.ncbi.nlm.nih.gov/pubmed/30110953
http://dx.doi.org/10.3390/cancers10080270

Ejemplares similares